Citigroup Inc. Boosts Stock Position in Henry Schein, Inc. (NASDAQ:HSIC)

Key Points

• Citigroup Inc. increased its holdings in Henry Schein, Inc. by 18.4%, owning approximately $23.63 million worth of 344,944 shares at the end of the latest quarter.
• Henry Schein's recent quarterly earnings report showed an EPS of $1.10, missing estimates by $0.09, with revenue slightly exceeding expectations at $3.24 billion.
• Several analysts have downgraded their price targets for Henry Schein, with the average target now set at $75.58 and a consensus rating of "Hold".

Citigroup Inc. increased its holdings in shares of Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 18.4% during the first quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 344,944 shares of the company's stock after acquiring an additional 53,526 shares during the period. Citigroup Inc. owned approximately 0.28% of Henry Schein worth $23,625,000 as of its most recent SEC filing.

A number of other institutional investors have also recently modified their holdings of HSIC. Palestra Capital Management LLC acquired a new stake in Henry Schein in the 4th quarter worth about $182,988,000. Steadfast Capital Management LP boosted its holdings in Henry Schein by 254.2% in the 4th quarter. Steadfast Capital Management LP now owns 1,637,808 shares of the company's stock worth $113,336,000 after buying an additional 1,175,408 shares during the last quarter. Hudson Bay Capital Management LP boosted its holdings in Henry Schein by 102.1% in the 4th quarter. Hudson Bay Capital Management LP now owns 1,465,007 shares of the company's stock worth $101,378,000 after buying an additional 740,007 shares during the last quarter. Raymond James Financial Inc. acquired a new stake in Henry Schein in the 4th quarter worth about $34,720,000. Finally, Ananym Capital Management LP acquired a new stake in Henry Schein in the 4th quarter worth about $32,628,000. 96.62% of the stock is currently owned by institutional investors and hedge funds.

Henry Schein Trading Down 0.1%

HSIC traded down $0.07 during trading hours on Friday, reaching $67.84. The company's stock had a trading volume of 1,675,382 shares, compared to its average volume of 2,075,710. The stock has a market cap of $8.23 billion, a PE ratio of 21.88, a P/E/G ratio of 2.24 and a beta of 0.81. The company has a debt-to-equity ratio of 0.51, a current ratio of 1.41 and a quick ratio of 0.78. Henry Schein, Inc. has a fifty-two week low of $60.56 and a fifty-two week high of $82.49. The business's 50-day moving average is $70.81 and its 200-day moving average is $70.78.

Henry Schein (NASDAQ:HSIC - Get Free Report) last announced its earnings results on Tuesday, August 5th. The company reported $1.10 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.19 by ($0.09). The firm had revenue of $3.24 billion during the quarter, compared to analysts' expectations of $3.22 billion. Henry Schein had a net margin of 3.05% and a return on equity of 14.36%. The firm's revenue for the quarter was up 3.3% compared to the same quarter last year. During the same period in the previous year, the firm earned $1.23 EPS. As a group, equities research analysts predict that Henry Schein, Inc. will post 4.74 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

HSIC has been the topic of several recent research reports. Leerink Partners set a $75.00 target price on Henry Schein in a report on Monday, July 14th. Barrington Research lowered their target price on Henry Schein from $86.00 to $78.00 and set an "outperform" rating on the stock in a report on Wednesday, August 6th. Stifel Nicolaus restated a "hold" rating and set a $75.00 target price (down from $80.00) on shares of Henry Schein in a report on Friday, July 25th. Baird R W cut Henry Schein from a "strong-buy" rating to a "hold" rating in a report on Monday, July 14th. Finally, JPMorgan Chase & Co. lowered their target price on Henry Schein from $80.00 to $76.00 and set an "overweight" rating on the stock in a report on Thursday, August 7th. Nine equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of "Hold" and a consensus target price of $75.58.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.